source
- FDA invites stakeholder input to shape a new Quantitative Medicine Innovation NetworkThe FDA announced it is looking for feedback from a broad range of stakeholders to help design a Quantitative Medicine Innovation Network (QMIN). The proposed QMIN would be a cross-sector platform…
- Liebel-Flarsheim recalls OPTIRAY imaging contrast agent after detecting plastic, metal and glass particlesLiebel-Flarsheim Company announced a recall of one lot of its OPTIRAY Imaging Bulk Package, a 350/500 mL vial of ioversol injection used for intra‑arterial and intravenous imaging. The recall was…